Generalized and focal dystonic syndromes: Possible therapy with salmon calcitonin

F. Patti; P. Marano; F. Nicoletti; G. Giammona; Fr R. Nicoletti

doi:10.1159/000115831

Generalized and focal dystonic syndromes: Possible therapy with salmon calcitonin

F. Patti, P. Marano, F. Nicoletti, G. Giammona, Fr R. Nicoletti

www.neuromed.it

Research output: Contribution to journal › Article › peer-review

Abstract

We report that repeated administration of salmon calcitonin (20-40 μg daily for 30 days) improves dystonic symptoms in patients affected by idiopathic torsion dystonia, blepharospasm-oromandibular dystonia syndrome or writer’s cramp syndrome. These results support the suggestion that calcitonin may act at central level influencing the extrapyramidal motor system.

Original language	English
Pages (from-to)	386-391
Number of pages	6
Journal	European Neurology
Volume	24
Issue number	6
DOIs	https://doi.org/10.1159/000115831
Publication status	Published - 1985

Keywords

Calcitonin
Dystonia
Extrapyramidal system

ASJC Scopus subject areas

Clinical Neurology
Neurology

Access to Document

10.1159/000115831

Cite this

@article{af794c3c8d184e80bafdd2f09091d517,

title = "Generalized and focal dystonic syndromes: Possible therapy with salmon calcitonin",

abstract = "We report that repeated administration of salmon calcitonin (20-40 μg daily for 30 days) improves dystonic symptoms in patients affected by idiopathic torsion dystonia, blepharospasm-oromandibular dystonia syndrome or writer{\textquoteright}s cramp syndrome. These results support the suggestion that calcitonin may act at central level influencing the extrapyramidal motor system.",

keywords = "Calcitonin, Dystonia, Extrapyramidal system",

author = "F. Patti and P. Marano and F. Nicoletti and G. Giammona and Nicoletti, {Fr R.}",

year = "1985",

doi = "10.1159/000115831",

language = "English",

volume = "24",

pages = "386--391",

journal = "European Neurology",

issn = "0014-3022",

publisher = "S. Karger AG",

number = "6",

}

TY - JOUR

T1 - Generalized and focal dystonic syndromes

T2 - Possible therapy with salmon calcitonin

AU - Patti, F.

AU - Marano, P.

AU - Nicoletti, F.

AU - Giammona, G.

AU - Nicoletti, Fr R.

PY - 1985

Y1 - 1985

N2 - We report that repeated administration of salmon calcitonin (20-40 μg daily for 30 days) improves dystonic symptoms in patients affected by idiopathic torsion dystonia, blepharospasm-oromandibular dystonia syndrome or writer’s cramp syndrome. These results support the suggestion that calcitonin may act at central level influencing the extrapyramidal motor system.

AB - We report that repeated administration of salmon calcitonin (20-40 μg daily for 30 days) improves dystonic symptoms in patients affected by idiopathic torsion dystonia, blepharospasm-oromandibular dystonia syndrome or writer’s cramp syndrome. These results support the suggestion that calcitonin may act at central level influencing the extrapyramidal motor system.

KW - Calcitonin

KW - Dystonia

KW - Extrapyramidal system

UR - http://www.scopus.com/inward/record.url?scp=0022344982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022344982&partnerID=8YFLogxK

U2 - 10.1159/000115831

DO - 10.1159/000115831

M3 - Article

C2 - 4065158

AN - SCOPUS:0022344982

SN - 0014-3022

VL - 24

SP - 386

EP - 391

JO - European Neurology

JF - European Neurology

IS - 6

ER -

Generalized and focal dystonic syndromes: Possible therapy with salmon calcitonin

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this